Post-IPO Debt - Sutro Biopharma
Investment Firm
Overview
Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Announced Date
Jun 26, 2023
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Sutro Biopharma raised $140000000 on 2023-06-26 in Post-IPO Debt
Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Company Funding History
12
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 01, 2006 |  Series A - Sutro Biopharma | 1 | - | 1.0M |
| Oct 16, 2007 | Venture Round - Sutro Biopharma | 2 | - | 305.0K |
| Dec 10, 2007 | Series B - Sutro Biopharma | 2 | - | 21.0M |
| Mar 30, 2009 | Series B - Sutro Biopharma | 2 | - | 15.0M |
Recent Activity
There is no recent news or activity for this profile.